NCT04994405

Brief Summary

This study design is a prospective, double-blinded, randomized controlled trial evaluating the quality of bloodless surgical field with lower tourniquet pressures based on systolic blood pressure (SBP) compared to standard tourniquet pressures. A secondary goal is to evaluate the effect of lower tourniquet pressures on post-operative tourniquet site pain. The rationale behind the study is to provide evidence-based guidelines on tourniquet use to continue providing quality surgical care while minimizing pain and potential harm to patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
93

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2022

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 19, 2021

Completed
18 days until next milestone

First Posted

Study publicly available on registry

August 6, 2021

Completed
11 months until next milestone

Study Start

First participant enrolled

July 15, 2022

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 27, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 27, 2024

Completed
Last Updated

April 1, 2025

Status Verified

March 1, 2025

Enrollment Period

2.2 years

First QC Date

July 19, 2021

Last Update Submit

March 31, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Quality of the bloodless surgical field provided by lower tourniquet pressures

    Surgeon-completed questionnaire rating the quality of the bloodless operative field using a 4-point Likert scale ranging from 1 (excellent) meaning no blood in the surgical field to 4 (poor) meaning blood in the surgical field obscures view throughout the procedure. This survey will be completed immediately post-operatively.

    Immediately After surgery in recovery room time

Secondary Outcomes (1)

  • Effect of lower tourniquet pressures based on SBP on post-operative tourniquet site pain

    Immediately After surgery in recovery room time

Study Arms (2)

Standard Pressure

NO INTERVENTION

The extremity tourniquet used during hand surgery for these participants will be the standard pressure of 250 mmHg.

Lower Tiered Pressures

EXPERIMENTAL

The study intervention is the inflation of the extremity tourniquet to a pressure lower than the standard pressure of 250 mmHg during hand surgery for these participants determined by tiered guidelines based on systolic blood pressure (SBP).

Procedure: Tourniquet Pressure

Interventions

The procedural intervention will be inflation of a pneumatic tourniquet to a lower than standard pressure as determined by the patient's SBP in hand and upper extremity surgery. The control will be inflation of a pneumatic tourniquet at a standard pressure of 250 mmHg in hand and upper extremity surgery. The tourniquet used will be the standard tourniquet used for hand and upper extremity surgery at our institutions - a tourniquet 18 inches in length and 3 inches in width manufactured by Stryker (Kalamazoo, MI) used in conjunction with a protective sleeve matched to the size of the tourniquet cuff which is provided by the manufacturer. Both pieces are supplied in a sterile packaging. No other tourniquets will be used.

Lower Tiered Pressures

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patient age 18 or older
  • Undergoing hand or upper extremity procedure
  • Tourniquet is used for procedure
  • Willingness and ability to consent

You may not qualify if:

  • Individuals with procedures that are over 120 minutes in length

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

NYU Langone Brooklyn

Brooklyn, New York, 11220, United States

Location

NYU Langone Orthopedic Hospital

New York, New York, 10010, United States

Location

NYU Langone Orthopedic Center

New York, New York, 10016, United States

Location

MeSH Terms

Conditions

Hand InjuriesArm Injuries

Condition Hierarchy (Ancestors)

Wounds and Injuries

Study Officials

  • Ali Azad

    NYU Langone Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 19, 2021

First Posted

August 6, 2021

Study Start

July 15, 2022

Primary Completion

September 27, 2024

Study Completion

September 27, 2024

Last Updated

April 1, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
Access Criteria
The investigator who proposed to use the data. Upon reasonable request. Requests should be directed to ali.azad@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.

Locations